Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Exercise timing around injections may matter for some women
Since January 2026, there have been six cases of acute liver injury in Victoria in people who have used an unapproved peptide product, labelled as Retatrutide
Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, showed up to 24.2% body weight reduction in Phase 2 trials
Apart from pancreatic islets, GIP and GLP-1 receptors have been identified in several other organs, including the intestine, heart, brain, and kidney
Improve blood sugar control: Making it beneficial for individuals with diabetes
These factors may seem unrelated to peptide dosing, but they substantially impact outcomes
US$ 25.56
US$ 25.60
US$ 23.15
US$ 22.49
US$ 23.96
US$ 26.48
